CAMP
CAMP4 THERAP (CAMP)
NASDAQ
$4.19+$0.01 (+0.36%)
Price as of Jun 03, 2026 4:10 PM EDT
  • $228.0M
    Market Cap
  • 105.15%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
3.5M
+436.50%
652,000
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
3.5M
+436.50%
652,000
N/A
Sales and Marketing Expense
659,000
+8.39%
608,000
N/A
Research and Development Expense
-38.2M
-1.58%
-38.8M
N/A
Depreciation and Amortization Expense
1.6M
-3.36%
1.7M
N/A
Total Operating Expenses
56.1M
+4.30%
53.7M
N/A
Operating Profit
-52.6M
-1.00%
-53.1M
N/A
Interest Income
2.2M
+63.46%
1.3M
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
2.2M
+63.46%
1.3M
N/A
Total Nonoperating Income and Expense
-27.8M
-2,247.11%
1.3M
N/A
Income before Taxes
-52.6M
-1.00%
-53.1M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
500,000
N/A
N/A
N/A
Net Income
-80.4M
+55.25%
-51.8M
N/A
Net Income from Continuing Operations Applicable to Common
-80.4M
+55.25%
-51.8M
N/A
Basic EPS and Net Income
-2.65
-76.00%
-11.04
N/A
Diluted EPS and Net Income
-2.65
-76.00%
-11.04
N/A
Basic Weighted Average Shares
30.4M
+547.76%
4.7M
N/A
Diluted Weighted Average Shares
30.4M
+547.76%
4.7M
N/A
Balance Sheet
Cash and Cash Equivalents
109.5M
+71.02%
64.0M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
109.5M
+71.02%
64.0M
N/A
Total Current Assets
114.1M
+71.87%
66.4M
N/A
Accumulated Depreciation
7.7M
+24.33%
6.2M
N/A
Property and Plant and Equipment and Net
2.3M
-39.37%
3.9M
N/A
Total Long-Term Assets
83,000
-97.85%
3.9M
N/A
Total Assets
117.8M
+50.44%
78.3M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
15.5M
+61.64%
9.6M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
29,000
+1,350.00%
2,000
N/A
Total Liabilities
70.1M
+362.34%
15.2M
N/A
Retained Earnings
-292.2M
+37.97%
-211.8M
N/A
Total Stockholders Equity
47.7M
-24.45%
63.1M
N/A
Total Shares Outstanding
51.9M
+157.64%
20.1M
N/A
Cash Flow
Cash from Operating Activities
-29.6M
-35.14%
-45.6M
N/A
Capital Expenditures
279,000
-36.73%
441,000
N/A
Cash from Investing Activities
-243,000
-44.90%
-441,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
75.9M
+5.90%
71.7M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
-1,502.43%
N/A
N/A
N/A
Return on Assets
-82.00%
N/A
N/A
N/A
Return on Equity
-145.07%
N/A
N/A
N/A
Revenue Growth
436.50%
N/A
N/A
N/A
Current Ratio
7.35
N/A
N/A
N/A
Cash Ratio
7.06
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow